Nicola Levasseur
Nurse Practitioner · Portsmouth, NHNPI 1285265447
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $989 and has fallen 89.0% since, to $109 in 2025. Among nurse practitioner clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$477
- Regeneron Healthcare Solutions, Inc.$298
- Novartis$252
- E.r. Squibb & Sons, L.L.C.$210
- Amgen$121
- Johnson & Johnson$114
- plus $585 from 11 others
What the payments were for
- Food & beverage$2,056100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $477 |
| Regeneron Healthcare Solutions, Inc. | 11 | $298 |
| Novartis | 11 | $252 |
| E.r. Squibb & Sons, L.L.C. | 13 | $210 |
| Amgen | 6 | $121 |
| Johnson & Johnson | 5 | $114 |
| Pfizer | 6 | $112 |
| Sun Pharmaceutical Industries Inc. | 4 | $86 |
| UCB, Inc. | 4 | $79 |
| Dermavant Sciences, Inc. | 3 | $70 |
| Sanofi | 2 | $64 |
| Lilly USA, LLC | 3 | $55 |
| Biofrontera Inc. | 2 | $39 |
| Merz North America, Inc. | 1 | $26 |
| Strata Skin Sciences, Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $13 |
How this compares
$2,056 in reported general payments places this provider in the 95th percentile of 714 nurse practitioner providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $78,148 |
| Clobetasol Propionate | 98 | $3,843 |
| Ketoconazole | 187 | $3,315 |
| Triamcinolone Acetonide | 165 | $2,265 |
| Fluorouracil | 27 | $1,547 |
| Mupirocin | 119 | $891 |
| Ammonium Lactate | 43 | $854 |
| Clindamycin Phosphate | 21 | $783 |
| Econazole Nitrate | 19 | $705 |
| Doxycycline Hyclate | 42 | $463 |
| Ciclopirox | 15 | $408 |
| ValacyclovirValacyclovir Hcl | 34 | $312 |
| Hydrocortisone | 24 | $170 |
| Cephalexin | 17 | $145 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Portsmouth
- Shareen LucasPortsmouth$7K
- Rossli DeloreyPortsmouth$3K
- Karen KadishPortsmouth$2K
- Melissa TimberlakePortsmouth$2K
- Amanda Bruno RobertsPortsmouth$831
- Jessica St JeanPelham$302K
- Michael RobustelliSomersworth$17K
- Denise McGrathLebanon$7K
- Lisa WilliamsBedford$7K
- Sonya AlyeaSomersworth$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.